About
Technology
Issues
FAQ
Links
Official Page
Adalimumab in Japanese patients with moderate to severe chronic plaque psoriasis: Efficacy and safety results from a Phase II/III randomized controlled study
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.